000 01683 a2200469 4500
005 20250515063459.0
264 0 _c20071015
008 200710s 0 0 eng d
022 _a0022-3042
024 7 _a10.1111/j.1471-4159.2007.04504.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRyu, Myung-Jeom
245 0 0 _aProteomic analysis of gamma-butyrolactone-treated mouse thalamus reveals dysregulated proteins upon absence seizure.
_h[electronic resource]
260 _bJournal of neurochemistry
_cAug 2007
300 _a646-56 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a4-Butyrolactone
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aCalcium-Binding Proteins
_xanalysis
650 0 4 _aConvulsants
_xpharmacology
650 0 4 _aCytoskeletal Proteins
_xanalysis
650 0 4 _aDown-Regulation
_xdrug effects
650 0 4 _aElectrophoresis, Gel, Two-Dimensional
650 0 4 _aEpilepsy, Absence
_xchemically induced
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aNerve Tissue Proteins
_xanalysis
650 0 4 _aNeurons
_xdrug effects
650 0 4 _aNeurotransmitter Agents
_xbiosynthesis
650 0 4 _aPresynaptic Terminals
_xmetabolism
650 0 4 _aProteomics
_xmethods
650 0 4 _aThalamus
_xdrug effects
650 0 4 _aTime Factors
700 1 _aKim, Daesoo
700 1 _aKang, Un-Beom
700 1 _aKim, Joon
700 1 _aShin, Hee-Sup
700 1 _aLee, Cheolju
700 1 _aYu, Myeong-Hee
773 0 _tJournal of neurochemistry
_gvol. 102
_gno. 3
_gp. 646-56
856 4 0 _uhttps://doi.org/10.1111/j.1471-4159.2007.04504.x
_zAvailable from publisher's website
999 _c16970912
_d16970912